The Platinum Age of Health Care

In today's Masters Series, originally from the July 20, 2022 issue of the free Health & Wealth Bulletin e-letter, Doc details how we reached the "platinum age of health care"... explains why this industry will only continue growing moving forward... and discusses how you can capitalize on this moneymaking opportunity... [Stansberry Research Logo] Delivering World-Class Financial Research Since 1999 [Stansberry Master Series] Editor's note: [Don't let this growing market pass you by](... You might not realize it, but our health care industry is rapidly changing – with new therapies and methods of drug development. And it's creating vast investment opportunities. That's why Retirement Millionaire editor Dr. David "Doc" Eifrig says it's crucial for you to understand why now is a great time to invest in the health care sector. In today's Masters Series, originally from the July 20, 2022 issue of the free Health & Wealth Bulletin e-letter, Doc details how we reached the "platinum age of health care"... explains why this industry will only continue growing moving forward... and discusses how you can capitalize on this moneymaking opportunity... --------------------------------------------------------------- The Platinum Age of Health Care By Dr. David Eifrig, editor, Retirement Millionaire The platinum age of health care is here... Just two years ago, a small study at the Memorial Sloan Kettering Cancer Center in New York City made medical history. The group was conducting a study using an experimental drug called dostarlimab to treat colorectal cancer. After six months of treatment, all 18 of their patients with colorectal cancer went into full remission. Dr. Hanna Sanoff of the University of North Carolina's Lineberger Comprehensive Cancer Center told NPR that she was incredibly optimistic about the results... and that researchers had never seen anything work in 100% of people in cancer medicine. This drug does not attack cancer directly. It teaches your own immune system to go after and kill the cancer. It received U.S. Food and Drug Administration approval in July 2023, giving researchers optimism about what the future may bring for cancer treatments. What's more, breakthroughs like this will be increasing in frequency. --------------------------------------------------------------- Recommended Links: ['I'm Cashing In My Chips']( Dr. David Eifrig just went on record: "If my investing ideas have ever helped you become wealthier or more secure... Please, give me your undivided attention for a few minutes. If an idea from Retirement Millionaire or any of my other research has saved you money... or helped you enjoy better health... if I've earned a little goodwill from you... I'm calling it in today. [You need to see this]( --------------------------------------------------------------- [MAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill...]( His system has found stocks that soared 1,174%, 2,123%, and 11,422%. But one investment he just uncovered in Washington could be his biggest discovery yet. It involves President Biden, Nancy Pelosi, trillions of dollars – and the biggest economic shift since 1958. [See for yourself]( --------------------------------------------------------------- Health care and medicine are taking off exponentially. New therapies, methods of drug development, payment mechanisms, and even the real estate of health care offer vast investment opportunities that are only increasing. A unique combination of technology, drug development, genetic understanding, massive new private investment, government funding, and more is on the verge of forever changing how we live and the quality of our lives. Scientists are doing things like hacking sheep embryos – turning off their ability to grow certain sheep organs, and then, in theory, inserting human genes instructing the embryo to grow a kidney or heart. This "replacement part" would be the exact genetic match of the donor. In a 2017 Washington Post article, Craig Venter – one of the first researchers to sequence the human genome – said: Recent leaps in the biosciences, combined with big data analysis, have led us to the cusp of a revolution in medicine. Not only have we learned to read and write the genetic code, now we can put it in digital form and translate it back into synthesized life. In theory, that gives our species control over biological design. Imagine a world where we could grow replacement parts for our bodies that would not be rejected by our immune system nor require a lifetime of antirejection medications. Now imagine being able to invest in those companies. That time is almost here. In the U.S. alone, health care is a $4.5 trillion market (and growing). Every single one of us is a customer. We always need health care – in good times and bad. And that means this massive industry is going to keep growing no matter what. It's complex, expensive, and confusing to access and pay for. It's also full of emotion and can be scary at times. That keeps a lot of investors away from the industry. But these reasons are exactly why we want to invest now. Today, there is a tremendous buying opportunity in health care stocks with many great businesses trading for ultra-low valuations. I'm going on record saying this is one of the best moneymaking opportunities I've seen in my decadeslong career. And it's all happening at a time when this space is churning out innovations and treatments that past generations could have only ever imagined. Everything I've done over the past four decades has been leading up to this moment. I've never been more excited about investing in health care. In a few years, this sector will produce some of the market's biggest winners... Here's to our health, wealth, and a great retirement, Dr. David Eifrig and the Health & Wealth Bulletin Research Team --------------------------------------------------------------- Editor's note: Doc is so bullish that he recently stepped forward to talk about the opportunity in health care stocks right now. He says artificial intelligence advancements are creating one of the best buying opportunities he has seen in his entire career. That's why he went on camera last week to reveal how you can position yourself to profit from these ongoing AI developments. [Click here to catch up on the full details](... You have received this e-mail as part of your subscription to Stansberry Digest. If you no longer want to receive e-mails from Stansberry Digest [click here](. Published by Stansberry Research. You’re receiving this e-mail at {EMAIL}. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberryresearch.com. Please note: The law prohibits us from giving personalized financial advice. © 2024 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 or [stansberryresearch.com](. Any brokers mentioned constitute a partial list of available brokers and is for your information only. Stansberry Research does not recommend or endorse any brokers, dealers, or investment advisors. Stansberry Research forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Stansberry Research (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation. This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.